Today: 16 June 2026

Wells Fargo stock slips as Fed minutes loom in thin year-end trading

Wells Fargo stock slips as Fed minutes loom in thin year-end trading

Wells Fargo shares fell 0.4% to $94.15 in afternoon New York trading Tuesday, tracking declines across U.S. bank stocks ahead of Federal Reserve meeting minutes. Investors focused on rate expectations for 2026 and the bank’s upcoming earnings in mid-January. The 10-year Treasury yield rose to 4.134% as financial sector ETFs also slipped in thin, year-end trading.
Pfizer stock today: PFE edges up after TD Cowen sticks with Hold as investors size up 2026 outlook

Pfizer stock today: PFE edges up after TD Cowen sticks with Hold as investors size up 2026 outlook

Pfizer shares edged up 0.1% to $25.03 Tuesday after TD Cowen reiterated a Hold rating and $30 price target, citing negative trends through 2030. The company projected 2026 revenue of $59.5 billion to $62.5 billion and warned of a “bumpy” period ahead as COVID demand fades and key patents expire. Shares have dropped over 50% since early 2023. Pfizer’s next earnings report is set for February 3.
30 December 2025
Natural gas price steadies near $4 as UNG stock climbs; traders await fresh U.S. storage data

Natural gas price steadies near $4 as UNG stock climbs; traders await fresh U.S. storage data

United States Natural Gas Fund (UNG) rose 1.6% to $13.26 in midday trading Tuesday as February Henry Hub futures held above $4 per mmBtu. U.S. gas storage fell by 166 billion cubic feet to 3,413 bcf for the week ended Dec. 19. Traders await the EIA storage report due Wednesday at noon ET. Leveraged gas ETFs moved sharply, with BOIL up 2% and KOLD down 2%.
Energy Fuels stock falls today as UUUU pulls back after uranium sales beat, new contracts

Energy Fuels stock falls today as UUUU pulls back after uranium sales beat, new contracts

Energy Fuels Inc shares fell 3.5% to $14.55 in Tuesday afternoon trading, underperforming uranium peers. The company said it exceeded 2025 uranium production guidance and completed two new long-term sales contracts with U.S. nuclear power generators. Energy Fuels expects to sell 360,000 pounds of U3O8 in Q4 for about $27 million at a weighted average price of $74.93 per pound.
30 December 2025
AI stocks today: Nvidia AI21 buyout talk hits tape as Meta climbs on Manus deal

AI stocks today: Nvidia AI21 buyout talk hits tape as Meta climbs on Manus deal

Nvidia traded flat after reports of advanced talks to buy Israel’s AI21 Labs for up to $3 billion. Meta gained 1.17% to $666.40 after announcing plans to acquire AI startup Manus, with the deal valued at $2 billion to $3 billion by a source. Broader tech stocks were mixed in light, year-end trading. Investors awaited Federal Reserve meeting minutes for signals on 2026 interest rates.
Bitcoin price today steadies near $88,000 as Fed minutes loom; crypto stocks edge higher

Bitcoin price today steadies near $88,000 as Fed minutes loom; crypto stocks edge higher

Bitcoin rose 0.8% to $88,320 in New York Tuesday afternoon. U.S. spot bitcoin ETFs saw $19.3 million in net outflows Monday, led by BlackRock’s IBIT. Coinbase shares edged up 0.2%, while Strategy gained 1.4% after disclosing a $108.8 million bitcoin purchase. Fed minutes are due at 2 p.m. ET.
Mineralys Therapeutics (MLYS) stock slides today as biotech weakens; FDA filing timeline in focus

Mineralys Therapeutics (MLYS) stock slides today as biotech weakens; FDA filing timeline in focus

Mineralys Therapeutics shares fell 3.3% to $35.61 by early afternoon Tuesday, underperforming biotech peers as investors awaited updates on its blood-pressure drug lorundrostat. The stock remains up 183% over 52 weeks but is down 25% from its November high. Mineralys plans to file for FDA approval of lorundrostat by early 2026 and expects Phase 2 results in the first quarter of that year.
Rhythm Pharmaceuticals (RYTM) stock falls today as biotech weakens; FDA decision stays in focus

Rhythm Pharmaceuticals (RYTM) stock falls today as biotech weakens; FDA decision stays in focus

Rhythm Pharmaceuticals shares dropped 4.2% to $107.85 in early afternoon trading Tuesday as biotech stocks broadly declined. Investors are awaiting an FDA decision on expanding Imcivree’s label, now expected by March 20, 2026. Board member Camille L. Bedrosian resigned effective immediately, according to an SEC filing. Major biotech ETFs fell over 1% while the broader market was flat.
S&P 500 Slips Before Fed Minutes as Meta Rises on Manus AI Deal

S&P 500 Slips Before Fed Minutes as Meta Rises on Manus AI Deal

Meta rose 1.2% after announcing plans to acquire AI startup Manus, reportedly valued at $2–3 billion. The Dow slipped 0.24%, S&P 500 fell 0.09%, and Nasdaq eased 0.07% in midday trading as investors awaited Federal Reserve meeting minutes. Apple and Nvidia edged lower, while Microsoft ticked up. T1 Energy climbed 3.7% after selling $160 million in clean-energy tax credits.
Warby Parker stock price today: WRBY falls nearly 4% in thin year-end trading

Warby Parker stock price today: WRBY falls nearly 4% in thin year-end trading

Warby Parker shares fell 3.9% to $22.11 in early afternoon trading Tuesday, underperforming the broader market amid thin year-end volumes. Nearly 3 million shares changed hands as investors awaited Federal Reserve meeting minutes. The company’s recent AI glasses partnership with Google has drawn attention, but traders remain focused on near-term fundamentals. Retail stocks were mixed, with National Vision down 1.7%.
30 December 2025
Dow Jones today: DJIA slips in thin year-end trade as Fed minutes loom

Dow Jones today: DJIA slips in thin year-end trade as Fed minutes loom

The Dow slipped 0.12% to 48,404.49 by early afternoon Tuesday, with financials and tech stocks weighing and communication services rising after Meta’s AI acquisition. Investors awaited Federal Reserve minutes due at 2 p.m. ET, following a recent rate cut that split policymakers. Treasury yields edged up, with the 10-year near 4.13%. The S&P 500 and Nasdaq were little changed in thin, year-end trading.
France vows stable electricity bills in 2026 — but new charges could still push costs up

France vows stable electricity bills in 2026 — but new charges could still push costs up

France will scrap its ARENH nuclear pricing scheme on Jan. 1, giving EDF more freedom to sell nuclear power. The government says regulated electricity tariffs should remain broadly stable in 2026 and 2027. A new mechanism will claw back excess EDF nuclear revenues above set thresholds, but officials say it is unlikely to trigger soon. Consumer group UFC-Que Choisir warns a separate policy could add about 50 euros to annual household energy bills.
30 December 2025

Stock Market Today

  • KFC Accelerates Shift to Chicken Tenders Amid Changing Consumer Preferences
    June 16, 2026, 1:44 PM EDT. KFC is pivoting from traditional bone-in wings to chicken tenders and sandwiches designed for convenience, reflecting a broader industry trend. This shift caters to consumers seeking easy-to-eat options, particularly while on the go. The move aligns KFC with rising demand for handheld, boneless poultry products, intensifying competition in the fast-food sector. Industry analysts note this change could reshape menu offerings and drive sales growth in the chicken segment.

Latest articles

Tesla Stock Slips as SpaceX Rally and FSD Scrutiny Test the AI Bull Case

Tesla Stock Slips as SpaceX Rally and FSD Scrutiny Test the AI Bull Case

16 June 2026
Tesla shares dropped 1.7% to $404.09 as Goldman Sachs raised Q2 delivery estimates to 420,000 vehicles but kept a Neutral rating and $375 target, while regulatory scrutiny of Full Self-Driving intensified after two U.S. senators urged an NHTSA review, highlighting ongoing risks for investors.
Micron Drops From Highs With AI Tailwind Facing Earnings Bar

Micron Drops From Highs With AI Tailwind Facing Earnings Bar

16 June 2026
Micron Technology shares fell 3.6% to $1,048.87 after a record high, as investors took profits in the hot AI memory trade ahead of the June 24 earnings call, where results will test whether booming AI-driven memory demand can justify the stock’s 800% run and high valuation, with analysts warning that any disappointment could hit both earnings expectations and the stock’s multiple.
Eos Energy shares jump as battery factory Line 2 goes live

Eos Energy shares jump as battery factory Line 2 goes live

16 June 2026
Eos Energy Enterprises jumped nearly 11% to $7.08 after launching commercial production at its second Pennsylvania battery facility, aiming for 4 GWh annual capacity by end-2026; shares surged as much as 13% intraday, but investors face dilution risk from a July rights offering and ongoing cash burn despite a $644.6 million backlog and soaring revenue.
Go toTop